Growth Metrics

Travere Therapeutics (TVTX) EPS (Basic) (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Travere Therapeutics 4.34 Bn 4.26 Bn 102.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -60.00%
Dec 31, 2025 -186.21%
Sep 30, 2025 307.14%
Jun 30, 2025 70.21%
Mar 31, 2025 32.86%
Dec 31, 2024 0.00%
Sep 30, 2024 23.08%
Jun 30, 2024 48.30%
Mar 31, 2024 -49.15%
Dec 31, 2023 -159.90%
Sep 30, 2023 247.01%
Jun 30, 2023 -5.51%
Mar 31, 2023 -23.30%
Dec 31, 2022 5.50%
Sep 30, 2022 12.80%
Jun 30, 2022 -4.17%
Mar 31, 2022 17.81%
Dec 31, 2021 -147.46%
Sep 30, 2021 7.81%
Jun 30, 2021 33.33%
Mar 31, 2021 59.49%
Dec 31, 2020 -438.64%
Sep 30, 2020 24.14%
Jun 30, 2020 -3,000.00%
Mar 31, 2020 102.86%
Dec 31, 2019 17.65%
Sep 30, 2019 7.61%
Jun 30, 2019 7.07%
Mar 31, 2019 -450.00%
Dec 31, 2018 86.57%
Sep 30, 2018 -139.29%
Jun 30, 2018 -21.74%
Mar 31, 2018 -2.22%
Dec 31, 2017 2.17%
Sep 30, 2017 -35.29%
Jun 30, 2017 -17.24%
Mar 31, 2017 -26.09%
Dec 31, 2016 77.00%
Sep 30, 2016 -170.27%
Jun 30, 2016 -219.35%
Mar 31, 2016 542.86%
Dec 31, 2015 -102.37%
Sep 30, 2015 504.11%
Jun 30, 2015 -150.00%
Mar 31, 2015 232.73%
Dec 31, 2014 -64.18%
Sep 30, 2014 -245.65%
Jun 30, 2014 114.15%
Mar 31, 2014 -345.21%
Dec 31, 2013 6.41%
Sep 30, 2013 -85.71%
Jun 30, 2013 4.55%
Nov 30, 2012 8.55%
Aug 31, 2012 0.26%
Nov 30, 2011 9.20%